NPAS4 and depressive symptom measurement: Supporting our findings, Gu et al. showed that patients with post-stroke depression had lower expression levels of NPAS4 in their peripheral blood mononuclear cells22, which makes NPAS4 a potential diagnostic biomarker in the future.